Octagon Capital Advisors’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.4M | Sell |
1,946,054
-113,333
| -6% | -$2.47M | 9.3% | 2 |
|
|
2025
Q1 | $38.1M | Hold |
2,059,387
| – | – | 7.37% | 4 |
|
|
2024
Q4 | $54.9M | Buy |
2,059,387
+83,000
| +4% | +$2.21M | 9.03% | 2 |
|
|
2024
Q3 | $46.4M | Buy |
1,976,387
+173,083
| +10% | +$4.07M | 7.22% | 5 |
|
|
2024
Q2 | $33.5M | Sell |
1,803,304
-140,532
| -7% | -$2.61M | 5.26% | 6 |
|
|
2024
Q1 | $34.7M | Buy |
+1,943,836
| New | +$34.7M | 4.16% | 6 |
|